إدارة الكولسترول دبي — رعاية الدهون وصحة القلب

Statins remain the cornerstone of cholesterol-lowering therapy and are among the most extensively studied medications in medicine. They work by inhibiting an enzyme (HMG-CoA reductase) in the liver that is essential for cholesterol production, resulting in reduced LDL levels by 30 to 50 percent depending on the statin type and dose. Beyond lowering cholesterol, statins have pleiotropic effects including reducing inflammation in artery walls, stabilizing existing plaques, and improving endothelial function. For patients who cannot tolerate statins or who do not reach target LDL with maximum statin doses, additional medications are available. Ezetimibe blocks cholesterol absorption in the intestine and can reduce LDL by an additional 15 to 20 percent. PCSK9 inhibitors are injectable medications that can lower LDL by 50 to 60 percent and are reserved for high-risk patients. Bempedoic acid offers another oral option for statin-intolerant patients.

Prevention is the foundation of cardiovascular health, and cholesterol management is central to that effort. In the UAE, where cardiovascular disease is the leading cause of death, proactive screening and treatment of dyslipidaemia can prevent thousands of heart attacks and strokes each year. A heart-healthy lifestyle forms the basis of cholesterol management: a Mediterranean-style diet rich in fruits, vegetables, whole grains, legumes, nuts, and olive oil; regular physical activity adapted to Dubai climate; maintaining a healthy weight; not smoking; and managing stress. For many patients, lifestyle changes alone are not enough to reach guideline targets, and combining medication with healthy habits provides the greatest cardiovascular protection. At DCDC, our cholesterol management program integrates testing, risk assessment, medication optimization, and lifestyle counseling into a coordinated plan designed to reduce your cardiovascular risk and support your long-term health.